Portola Pharmaceuticals Inc Conference Call on Bevyxxa (betrixaban) Approval

23/6/2017 16:30

Llamada en conferencia Portola Pharmaceuticals Inc

Portola Pharmaceuticals Inc Conference call or earnings call will be held on 23-jun-2017
During the earnings conference call’s session, Portola Pharmaceuticals Inc will provide updated information and financial performance report status.
In order to join the earning call, dial the conference’s bridge and key in the PIN code. Contact Portola Pharmaceuticals Inc for this information
More and more companies choose to conduct their earnings calls through conference calls and online meetings and it’s important to keep up to date with all relevant information.
Need a conference calls service solution? Try QCONF conferencing today, Sign up now and get 5 free conference calls (no credit card required)
Is this is your first earnings call? Check out Nasdaq guide for how to read an earnings report?
We are a biopharmaceutical company focused on the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders and inflammation for patients who currently have limited or no approved treatment options. We are advancing our three wholly-owned compounds using novel biomarker and genetic approaches that may increase the likelihood of clinical, regulatory and commercial success of our potentially life-saving therapies. Two of these compounds were discovered through our internal research efforts and one was discovered by Portola scientists during their time at a prior company. Our Phase 3 programs address significant unmet medical needs in the area of thrombosis, or blood clots. Betrixaban, a U.S.    
Leer más Llamada en conferencia

Portola Pharmaceuticals Inc (PTLA)

270 East Grand Avenue, South San Francisco California 94080, United States